MALARIA
(Diagnosis, Diagnostics, Immunodiagnosis,
Immunodiagnostics,
4137.
Alessio M. Cytoadherence of Plasmodium falciparum-infected erythrocytes
is mediated by a redox-dependent conformational fraction of CD36. J Immunol
2001 Dec 1;167(11):6510-7
4138.
Amaral L, Viveiros M, Kristiansen JE. Phenothiazines: potential
alternatives for the management of antibiotic resistant infections of
tuberculosis and malaria in developing countries. Trop Med Int Health
2001 Dec;6(12):1016-22
4139.
Arevalo-Herrera M, Herrera S. Plasmodium
vivax malaria vaccine development. Mol Immunol
2001 Dec;38(6):443-55
4140.
B, Gay F, Looareesuwan S. Association of splenomegaly with cerebral
malaria and decreased concentrations of reactive nitrogen intermediates in
Thailand. Am J Trop Med Hyg 2001
Nov;65(5):639-43
4141.
Basco LK, Ringwald P. Molecular epidemiology of malaria in Yaounde,
Cameroon. VIII. Multiple Plasmodium falciparum infections in symptomatic
patients. Am J Trop Med Hyg 2001
Dec;65(6):798-803
4142.
Bhat GP, Surolia N. In vitro antimalarial activity of extracts of three
plants used in the traditional medicine of India. Am J Trop Med Hyg
2001 Oct;65(4):304-8
4143.
Biswas R, Sengupta G, Mundle M: Controlled study
on haemograms of malaria
patients in Calcutta. Indian J Malar 1999, 36(1-2), 42-8. (015287) Aug 1, 2023
4144.
Bradbury J. Haemoglobin C protection against
malaria. Lancet 2001 Nov
17;358(9294):1702
4145.
Brice GT, Graber NL, Hoffman SL, Doolan DL. Expression of the chemokine
MIG is a sensitive and predictive marker for antigen-specific, genetically
restricted IFN-gamma production and IFN-gamma-secreting cells. J Immunol Methods
2001 Nov 1;257(1-2):55-69
4146.
Brower V. Tackling the most difficult diseases. Genetics and genomics
open new strategies to fight vector-borne diseases. EMBO Rep 2001 Oct;2(10):875-7
4147.
Bryceson A. A policy for leishmaniasis with respect to the prevention and
control of drug resistance. Trop Med Int Health
2001 Nov;6(11):928-34
4148.
Burgess DC, Kain KC. The performance and utility of rapid diagnostic
assays for Plasmodium falciparum malaria in a field setting in the Lao People's
Democratic Republic. Ann Trop Med Parasitol
2001 Oct;95(7):671-7
4149.
Chongsuphajaisiddhi T, White NJ. Factors contributing to anemia after
uncomplicated falciparum malaria. Am J Trop Med Hyg
2001 Nov;65(5):614-22
4150.
Cian F, Declich S. HIV, malaria parasites, and acute febrile episodes in
Ugandan adults: a case-control study. AIDS
2001 Dec 7;15(18):2445-50
4151.
Corbellino M. Subacute malaria due to Plasmodium falciparum and the role
of polymerase chain reaction. Clin Infect Dis
2001 Nov 1;33(9):1614-5
4152.
Cunha MG, Rodrigues MM, Soares IS. Comparison of the immunogenic
properties of recombinant proteins representing the Plasmodium vivax vaccine
candidate MSP1(19) expressed in distinct bacterial vectors. Vaccine
2001 Nov 12;20(3-4):385-96
4153.
D'Alessandro U, Buttiens H. History and importance of antimalarial drug
resistance. Trop Med Int Health 2001
Nov;6(11):845-8
4154.
Foca A, Matera G, Barreca GS, Gagliardi F, Apuzzo G, Guaglianone L.
Imported malaria in pregnancy due to Plasmodium falciparum. J Travel Med
2001 Nov-Dec;8(6):331-2
4155.
Goodman CA, Coleman PG, Mills AJ. Changing the first line drug for
malaria treatment--cost-effectiveness analysis with highly uncertain
inter-temporal trade-offs. Health Econ 2001
Dec;10(8):731-49
4156.
Gupta D, Chugh K, Sachdev A, Soni A. ICU management of severe malaria. Indian J Pediatr
2001 Nov;68(11):1057-61
4157.
Haldar K, Samuel BU, Mohandas N, Harrison T, Hiller NL. Transport
mechanisms in Plasmodium-infected erythrocytes: lipid rafts and a tubovesicular
network. Int J Parasitol 2001
Oct;31(12):1393-401
4158.
Hemingway J. Identification of a novel class of insect glutathione S-transferases
involved in resistance to DDT in the malaria vector Anopheles gambiae. Biochem J
2001 Oct 15;359(Pt 2):295-304
4159.
Kaushik A, Gahlot S, Kaushik S,
Verma B L. Rapid manual test for falciparum malaria. Indian Pediat 2001, 38(6),
650-4. (017313).1 Sept 2001.
4160.
Kawamoto F. Detection of Plasmodium ovale by the ICT malaria P.f/P.v.
immunochromatographic test. Acta Trop 2001
Dec 21;80(3):283-4
4161.
Kirk K. Malaria. A voracious
creature. Lancet 2001 Dec;358
Suppl:S41
4162.
Krettli AU, Andrade-Neto VF, Brandao MG, Ferrari WM. The search for new
antimalarial drugs from plants used to treat fever and malaria or plants
ramdomly selected: a review. Mem Inst Oswaldo Cruz
2001 Nov;96(8):1033-42
4163.
L, Sergheraert C, Grellier P, Schirmer RH, Becker K. A prodrug form of a
Plasmodium falciparum glutathione reductase inhibitor conjugated with a
4-anilinoquinoline. J Med Chem 2001
Nov 22;44(24):4268-76
4164.
Leke RG. The state of immunology in Africa: HIV/AIDS and malaria. Curr
Opin Immunol 2001 Oct;13(5):523-7
4165.
Mayxay M, Chotivanich K, Pukrittayakamee S, Newton P, Looareesuwan S,
White NJ. Contribution of humoral immunity to the therapeutic response in
falciparum malaria. Am J Trop Med Hyg 2001
Dec;65(6):918-23
4166.
Merten M, Thiagarajan P. Role for sulfatides
in platelet aggregation. Circulation
2001 Dec 11;104(24):2955-60
4167.
Modiano D. Antimalarial antibody
levels and IL4 polymorphism in the Fulani of West Africa. Genes Immun
2001 Nov;2(7):411-4
4168.
Nacer A, Berry L, Slomianny C, Mattei D. Plasmodium falciparum signal
sequences: simply sequences or special signals? Int J Parasitol 2001 Oct;31(12):1371-9
4169.
Oguariri RM, Borrmann S, Klinkert MQ, Kremsner PG, Kun JF. High
prevalence of human antibodies to recombinant Duffy binding-like alpha domains
of the Plasmodium falciparum-infected erythrocyte membrane protein 1 in
semi-immune adults compared to that in nonimmune children. Infect Immun 2001 Dec;69(12):7603-9
4170.
Okech BA, Nalunkuma A, Okello D, Pang XL, Suzue K, Li J, Horii T, Egwang
TG. Natural human immunoglobulin G subclass responses to Plasmodium falciparum
serine repeat antigen in Uganda. Am J Trop Med Hyg
2001 Dec;65(6):912-7
4171.
Olliaro P, Taylor WR, Rigal J. Controlling malaria: challenges and
solutions. Trop Med Int Health 2001
Nov;6(11):922-7
4172.
Ouellette M. Biochemical and molecular mechanisms of drug resistance in parasites. Trop Med Int Health
2001 Nov;6(11):874-82
4173.
Pennisi E. Genes and disease. Genetic change wards off malaria. Science
2001 Nov 16;294(5546):1439
4174.
Pinder M, Hill AV, Plebanski M. Unique
T cell effector functions elicited by Plasmodium falciparum epitopes in
malaria-exposed Africans tested by three T cell assays. J Immunol
2001 Oct 15;167(8):4729-37
4175.
Rajagopal V, Appavoon N C,
Sarangapani T D, Mani S: Comparative study on microscopic detection of malaria
parasites under conventional thick film and concentration by saponin
haemolysis.Indian J Malar 1999, 36(1-2), 49-51. (015249), Aug 1, 2023
4176.
Rajesh Kumar: Study of consequences of malaria among sicklers. Proc
Indian Sci Congr Ass- Pt II, Sect- II 1999, 28-9. (016449). Aug 16, 2001.
4177.
Rhee MS, Akanmori BD, Waterfall M, Riley EM. Changes in cytokine
production associated with acquired immunity to Plasmodium falciparum malaria.
Clin Exp Immunol 2001
Dec;126(3):503-10
4178.
Rowe AK, Onikpo F, Lama M, Cokou F, Deming MS. Management of childhood
illness at health facilities in Benin: problems and their causes. Am J Public
Health 2001 Oct;91(10):1625-35
4179.
Rubio JM, Berzosa PJ, Benito A. Amplified fragment length polymorphism (AFLP)
protocol for genotyping the malarial parasite Plasmodium falciparum.
Parasitology 2001 Oct;123(Pt
4):331-6
4180.
Saito-Ito A, Akai Y, He S, Kimura M, Kawabata M. A rapid, simple and
sensitive flow cytometric system for detection of Plasmodium falciparum.
Parasitol Int 2001 Nov;50(4):249-57
4181.
Senior K. "Imperfect" vaccines may encourage more potent
pathogens, model suggests. Lancet 2001
Dec 15;358(9298):2055
4182.
Snounou G. Association of genetic mutations in Plasmodium vivax dhfr with
resistance to sulfadoxine-pyrimethamine: geographical and clinical correlates.
Antimicrob Agents Chemother 2001
Nov;45(11):3122-7
4183.
Tarimo DS, Minjas JN, Bygbjerg IC. Perception of chloroquine efficacy and
alternative treatments for uncomplicated malaria in children in a holoendemic
area of Tanzania: implications for the change of treatment policy. Trop Med Int
Health 2001 Dec;6(12):992-7
4184.
Tjitra E, Suprianto S, Currie BJ, Morris PS, Saunders JR, Anstey NM.
Therapy of uncomplicated falciparum malaria: a randomized trial comparing
artesunate plus sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine alone
in Irian Jaya, Indonesia. Am J Trop Med Hyg
2001 Oct;65(4):309-17
4185.
Tjitra E, Suprianto S, Dyer ME, Currie BJ, Anstey NM. Detection of
histidine rich protein 2 and panmalarial ICT Malaria Pf/Pv test antigens after
chloroquine treatment of uncomplicated falciparum malaria does not reliably
predict treatment outcome in eastern Indonesia. Am J Trop Med Hyg
2001 Nov;65(5):593-8
4186.
Toure FS, Mavoungou E, Ndong JM, Tshipamba P, Deloron P. Erythrocyte
binding antigen (EBA-175) of Plasmodium falciparum: improved genotype
determination by nested polymerase chain reaction. Trop Med Int Health
2001 Oct;6(10):767-9
4187.
Trial Team. Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium
falciparum infection in semi-immune adult men in The Gambia: a randomised trial.
Lancet 2001 Dec 8;358(9297):1927-34
4188.
Tsuji M, Zavala F. Peptide-based subunit vaccines against pre-erythrocytic
stages of malaria parasites. Mol Immunol 2001
Dec;38(6):433-42
4189.
Urquiza M, Ocampo M, Patarroyo ME, Patarroyo MA. Plasmodium vivax:
functional analysis of a highly conserved PvRBP-1 protein region. Mol Biochem
Parasitol 2001 Oct;117(2):229-34
4190.
Yapabandara AM, Curtis CF, Wickramasinghe MB, Fernando WP. Control of
malaria vectors with the insect growth regulator pyriproxyfen in a gem-mining
area in Sri Lanka. Acta Trop 2001
Dec 21;80(3):265-76
Back |